Triple Negative Breast Cancer Clinical Trials
Find clinical trials for triple negative breast cancer. Search for triple negative breast cancer clinical trials in different cities and states across the United States.
ZN-c3, Carboplatin, PembrolizumabZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in MTNBC
Sponsor:
Filipa Lynce, MD
Location:
Code:
NCT06351332
Conditions
Breast Cancer
Breast Cancer Female
Triple Negative Breast Cancer
Hormone Receptor Negative Malignant Tumor Breast Triple
HER2-negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Azenosertib
Carboplatin
Pembrolizumab
Adagloxad SimoleninStudy of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
Sponsor:
OBI Pharma, Inc
Location:
Code:
NCT03562637
Conditions
Triple Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
adagloxad simolenin combined with OBI-821
Globo H IHC Assay
Standard of care treatment
BAL0891BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
SillaJen, Inc.
Location:
Code:
NCT05768932
Conditions
Advanced Solid Tumor
TNBC - Triple-Negative Breast Cancer
Gastric Cancer
Leukemia Acute Myeloid Leukemia (AML)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BAL0891
Carboplatin
Paclitaxel
SBRTInvestigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT03808337
Conditions
Triple Negative Breast Cancer
Non Small Cell Lung Cancer
Metastatic Breast Cancer
Metastatic Non-Small Cell Lung Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Stereotactic Body Radiotherapy/SBRT
Systemic Therapy/Standard of Care
Dendritic Cell VaccineA First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Location:
Code:
NCT05809752
Conditions
Leptomeningeal Disease
Triple Negative Breast Cancer
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dendritic Cell Vaccine
PBA-0405A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Sponsor:
Pure Biologics S.A.
Location:
Code:
NCT06273852
Conditions
Head and Neck Squamous Cell Carcinoma
Soft Tissue Sarcoma Adult
Triple Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PBA-0405
TM & CapecitabineA Study of Tetrathiomolybdate (TM) Plus Capecitabine
Sponsor:
Dartmouth-Hitchcock Medical Center
Location:
Code:
NCT06134375
Conditions
Triple Negative Breast Cancer
Residual Disease
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Tetrathiomolybdate
Capecitabine
Pembrolizumab
LY4101174A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06238479
Conditions
Metastatic Solid Tumor
Recurrent Solid Tumor
Advanced Solid Tumor
Urinary Bladder Neoplasm
Triple Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY4101174
AO-252A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors
Sponsor:
A2A Pharmaceuticals Inc.
Location:
Code:
NCT06136884
Conditions
Triple Negative Breast Cancer
High Grade Serous Ovarian Cancer
Endometrial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AO-252
BG-68501A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Sponsor:
BeiGene
Location:
Code:
NCT06257264
Conditions
Breast Cancer
Small Cell Lung Cancer
Ovarian Cancer
Gastric Cancer
Hormone-receptor-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BG-68501
Fulvestrant
BGB-43395